Occular formulation comprising bromocriptine
US4654345A · kind A · utility
13Cited by
5References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 18, 1985 |
| Grant date | Mar 31, 1987 |
| Priority date | — |
| Expiry date | Oct 18, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lyophylisates comprising bromocriptine or an acid addition salt thereof capable of reconstitution in an isotonic vehicle to provide a stable formulation for occular instillation, useful e.g. in the treatment of glaucoma. Typical lyophylisates in accordance with the invention comprise: a lyophylisable acid, e.g. methane sulfonic acid, an acid addition salt of bromocriptine with said acid, e.g. bromocriptine mesylate, benzalkonium chloride and a lyophylisate matrix material.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.